HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Winkler, D. G. Articles by Vojtek, A. B. Search for Related Content PubMed PubMed Citation Articles by Winkler, D. G. Articles by Vojtek, A. B. Social Bookmarking                      What's this?

Volume 272, Number 39, Issue of September 26, 1997 pp. 24402-24409
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Identification and Characterization of Mutations in Ha-Ras That Selectively Decrease Binding to cRaf-1

(Received for publication, April 7, 1997, and in revised form, June 30, 1997)

From the Fred Hutchinson Cancer Research Center, Seattle, Washington 98109

The oncoprotein Ras transforms cells by binding to one or more effector proteins. Effector proteins have been identified by their ability to bind to Ras in the GTP but not GDP form, and by their requirement for the Ras effector domain for binding. The best understood Ras effectors are serine/threonine kinases of the Raf family, but other candidate Ras effectors, including a Ral guanine nucleotide dissociation stimulator and phosphatidylinositol 3-kinase (PI3 kinase) have also been identified. To investigate the mechanism of binding of cRaf-1 to Ras, and to investigate the roles of other candidate Ras effectors in transformation, we have isolated and characterized mutants of activated Ras with decreased binding to cRaf-1 relative to other candidate effectors. Examination of these mutants indicates that surface-exposed residues of Ras outside the minimal effector domain interact differentially with cRaf-1 and other Ras-binding proteins, and that fibroblast transformation correlates with cRaf-1 binding and mitogen-activated protein (MAP) kinase activation. Furthermore, activation of PI3 kinase can occur in the absence of significant MAP kinase activation, suggesting that PI3 kinase activation is a primary effect of Ras.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. Owen, L. J. Campbell, K. Littlefield, K. A. Evetts, Z. Li, D. B. Sacks, P. N. Lowe, and H. R. Mott The IQGAP1-Rac1 and IQGAP1-Cdc42 Interactions: INTERFACES DIFFER BETWEEN THE COMPLEXES J. Biol. Chem., January 18, 2008; 283(3): 1692 - 1704. [Abstract] [Full Text] [PDF]

				A. V. Cybulsky, T. Takano, J. Papillon, K. Bijian, and J. Guillemette Activation of the extracellular signal-regulated kinase by complement C5b-9 Am J Physiol Renal Physiol, September 1, 2005; 289(3): F593 - F603. [Abstract] [Full Text] [PDF]

				P. Rodriguez-Viciana, C. Sabatier, and F. McCormick Signaling Specificity by Ras Family GTPases Is Determined by the Full Spectrum of Effectors They Regulate Mol. Cell. Biol., June 1, 2004; 24(11): 4943 - 4954. [Abstract] [Full Text] [PDF]

				K. Bijian, T. Takano, J. Papillon, A. Khadir, and A. V. Cybulsky Extracellular matrix regulates glomerular epithelial cell survival and proliferation Am J Physiol Renal Physiol, February 1, 2004; 286(2): F255 - F266. [Abstract] [Full Text] [PDF]

				C. Missero, M. T. Pirro, and R. Di Lauro Multiple Ras Downstream Pathways Mediate Functional Repression of the Homeobox Gene Product TTF-1 Mol. Cell. Biol., April 15, 2000; 20(8): 2783 - 2793. [Abstract] [Full Text]

				C. Fenwick, S. Na, R. E. Voll, H. Zhong, S. Im, J. W. Lee, and S. Ghosh A Subclass of Ras Proteins That Regulate the Degradation of IB Science, February 4, 2000; 287(5454): 869 - 873. [Abstract] [Full Text]

				A. Rebollo and C. Martinez-A Ras Proteins: Recent Advances and New Functions Blood, November 1, 1999; 94(9): 2971 - 2980. [Full Text] [PDF]

				V. Nancy, R. M. F. Wolthuis, M.-F. de Tand, I. Janoueix-Lerosey, J. L. Bos, and J. de Gunzburg Identification and Characterization of Potential Effector Molecules of the Ras-related GTPase Rap2 J. Biol. Chem., March 26, 1999; 274(13): 8737 - 8745. [Abstract] [Full Text] [PDF]

				D. G. Winkler, R. E. Cutler Jr., J. K. Drugan, S. Campbell, D. K. Morrison, and J. A. Cooper Identification of Residues in the Cysteine-rich Domain of Raf-1 That Control Ras Binding and Raf-1 Activity J. Biol. Chem., August 21, 1998; 273(34): 21578 - 21584. [Abstract] [Full Text] [PDF]

				A. B. Vojtek and C. J. Der Increasing Complexity of the Ras Signaling Pathway J. Biol. Chem., August 7, 1998; 273(32): 19925 - 19928. [Full Text] [PDF]

				M. Ohnishi, Y. Yamawaki-Kataoka, K.-i. Kariya, M. Tamada, C.-D. Hu, and T. Kataoka Selective Inhibition of Ras Interaction with Its Particular Effector by Synthetic Peptides Corresponding to the Ras Effector Region J. Biol. Chem., April 24, 1998; 273(17): 10210 - 10215. [Abstract] [Full Text] [PDF]